Sort
25,944 grants matching “neurodegeneration”
Imaging tau, amyloid, and neurodegeneration in PPA
$854,998Bradford C Dickerson · Massachusetts General Hospital · R01 · FY2018 · DC
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG
$854,981Patrick L. Purdon · Massachusetts General Hospital · R01 · FY2017 · AG
Omics Analyses of HIV and Substance Use Disorder
$854,351Vez Repunte-Canonigo · Scripps Research Institute, The · R01 · FY2022 · DA
Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease
$854,102Anton Iliuk · Tymora Analytical Operations, Llc · R44 · FY2025 · AG
Genomic instability in aging and cancer
$854,009Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Stem cells and aging
$854,009Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
The role of autophagy in aging and metabolism
$854,009Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
The biology of the sirtuins
$854,009Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Genomic sequencing to establish a macaque genotype and phenotype research resource
$853,754Betsy M Ferguson · Oregon Health & Science University · R24 · FY2020 · OD
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
$853,100Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2020 · AG
Mechanisms of Parkinson Disease and Related Disorders
$852,963David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Targeting ApoE4 as a Therapeutic Strategy for Alzheimer's Disease
$852,235Robert W. Mahley · J. David Gladstone Institutes · U01 · FY2012 · AG
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
$851,784Kurt R. Brunden · University Of Pennsylvania · U01 · FY2021 · AG
Determining the role of OXR1 in aging and Alzheimer's disease
$851,414Pankaj Kapahi · Buck Institute For Research On Aging · R56 · FY2021 · AG
RNA Targeted Drug Discovery and Development for Parkinson Disease
$851,067M. Maral Mouradian · Rbhs-Robert Wood Johnson Medical School · UH3 · FY2021 · NS
Neuroimaging Core I
$851,023John A Detre · University Of Pennsylvania · P30 · FY2019 · AG
Core B: The Clinical and Translational Research Core
$850,451Xue K Zhong · Cleveland Clinic Foundation · P20 · FY2017 · GM
Role of Neurotrophins in the Development of the Mammalian Nervous System
$848,710Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Uncovering the origin of hypermutability in adult brains
$848,578Alexej Abyzov · Mayo Clinic Rochester · R01 · FY2025 · MH
Biochemistry, Cellular and Molecular Biology Program
$848,437Carolyn E Machamer · Johns Hopkins University · T32 · FY2013 · GM
Deep Pathological Phenotyping in Frontotemporal Dementia and Motor Neuron Disease.
$848,236William W Seeley · University Of California, San Francisco · R01 · FY2022 · NS
Transgenic Huntington's disease monkey resource
$848,211Anthony Wing Sang Chan · Emory University · R24 · FY2016 · OD
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
$848,183Jasmeer P Chhatwal · Massachusetts General Hospital · R01 · FY2023 · AG
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
$848,183Jasmeer P Chhatwal · Massachusetts General Hospital · R01 · FY2024 · AG
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
$848,183Jasmeer P Chhatwal · Massachusetts General Hospital · R01 · FY2022 · AG